ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,386,565 | -44.7% | 826,095 | -0.8% | 0.01% | -43.8% |
| Q2 2023 | $7,934,106 | +48.3% | 832,540 | +71.2% | 0.02% | +33.3% |
| Q1 2023 | $5,348,640 | -25.4% | 486,240 | +0.3% | 0.01% | -25.0% |
| Q4 2022 | $7,171,370 | -23.3% | 484,552 | -1.0% | 0.02% | -30.4% |
| Q3 2022 | $9,352,000 | +15.5% | 489,345 | +28.8% | 0.02% | +21.1% |
| Q2 2022 | $8,095,000 | -15.2% | 379,895 | -23.3% | 0.02% | 0.0% |
| Q1 2022 | $9,544,000 | +9.7% | 495,450 | +18.1% | 0.02% | +11.8% |
| Q4 2021 | $8,704,000 | -6.6% | 419,674 | +7.6% | 0.02% | -10.5% |
| Q3 2021 | $9,316,000 | -14.1% | 389,938 | -1.8% | 0.02% | -13.6% |
| Q2 2021 | $10,840,000 | +118.8% | 397,216 | +132.0% | 0.02% | +100.0% |
| Q1 2021 | $4,954,000 | +356.2% | 171,203 | +343.5% | 0.01% | +450.0% |
| Q4 2020 | $1,086,000 | +69.4% | 38,604 | +76.5% | 0.00% | 0.0% |
| Q3 2020 | $641,000 | +182.4% | 21,876 | +191.7% | 0.00% | +100.0% |
| Q2 2020 | $227,000 | +1.3% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $224,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|